Efficacy and safety of alemtuzumab in patients with relapsing-remitting multiple sclerosis who relapsed on prior therapy: Four-year follow-up of the Care-MS II study
2014 ◽
Vol 3
(6)
◽
pp. 756
◽
2014 ◽
Vol 3
(6)
◽
pp. 761-762
◽
2012 ◽
Vol 78
(Meeting Abstracts 1)
◽
pp. S01.004-S01.004
◽
2009 ◽
Vol 2009
◽
pp. 99-103
2018 ◽
Vol 11
◽
pp. 175628641879640
◽
2020 ◽
Vol 13
◽
pp. 175628642096835